Compare
Ascend Wellness Holdings, Inc. vs Cresco Labs Inc. vs Tilray Brands, Inc. vs USANA Health Sciences Inc
| Latest fiscal year | Ascend Wellness Holdings, Inc. AAWH | Cresco Labs Inc. CRLBF | Tilray Brands, Inc. TLRY | USANA Health Sciences Inc USNA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-05-31 | 2026-01-03 |
| Revenue | $500.58M | $655.85M | $915.45M | $925.26M |
| Revenue growth (YoY) | -10.9% | -9.5% | +11.5% | +8.3% |
| Gross margin | 33.9% | 49.5% | 28.4% | 78.3% |
| Operating margin | -3.4% | -4.3% | -6.9% | 4.0% |
| Net margin | -23.6% | -20.6% | -13.3% | 1.2% |
| Net income | -$118.19M | -$135.41M | -$121.40M | $10.76M |
| EPS (Diluted) | -$0.58 | -$0.38 | -$1.09 | $0.58 |
| Operating cash flow | $38.05M | $72.89M | -$69.14M | $22.35M |
| Free cash flow | $12.04M | $37.75M | n/a | $8.53M |
| Cash & equivalents | $85.68M | $57.90M | $225.98M | $158.38M |
| Total assets | $907.93M | $1.20B | $2.33B | $742.91M |
| Total liabilities | $954.55M | $944.80M | $733.14M | $156.64M |
| Shareholders' equity | -$46.62M | $340.45M | $1.61B | $533.10M |
| Return on year-end equity | n/a | -39.8% | -7.5% | 2.0% |
| Shares outstanding | 202.22M | n/a | 131.68M | 18.28M |
Revenue, most recent five fiscal years
| Fiscal year | Ascend Wellness Holdings, Inc. | Cresco Labs Inc. | Tilray Brands, Inc. | USANA Health Sciences Inc |
|---|---|---|---|---|
| Latest | $500.58M Ended 2025-12-31 | $655.85M Ended 2025-12-31 | $915.45M Ended 2026-05-31 | $925.26M Ended 2026-01-03 |
| 1 year earlier | $561.60M Ended 2024-12-31 | $724.34M Ended 2024-12-31 | $821.31M Ended 2025-05-31 | $854.50M Ended 2024-12-28 |
| 2 years earlier | $518.59M Ended 2023-12-31 | $770.88M Ended 2023-12-31 | $788.94M Ended 2024-05-31 | $921.01M Ended 2023-12-30 |
| 3 years earlier | $405.93M Ended 2022-12-31 | n/a | $627.12M Ended 2023-05-31 | $998.60M Ended 2022-12-31 |
| 4 years earlier | $332.38M Ended 2021-12-31 | n/a | $628.37M Ended 2022-05-31 | $1.19B Ended 2022-01-01 |